Clinical Trials Directory

Trials / Completed

CompletedNCT04250831

Dietary Fibre and Chromium Picolinate Efficacy in Overweight and Obese Women

Impact of Dietary Fibre and Chromium Picolinate on Satiety, Satiation, Weight Loss and Gut Microbiome Composition in Overweight and Obese Women

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
12 (actual)
Sponsor
University of Roehampton · Academic / Other
Sex
Female
Age
22 Years – 70 Years
Healthy volunteers
Accepted

Summary

Obesity is one of the greatest causes of preventable morbidity and mortality worldwide with the main treatments requiring significant changes to lifestyle, particularly dieting and physical exercise. Glucomannan is a dietary fibre that expands in the stomach, creating the feeling of fulness, while chromium can regulate insulin response.

Detailed description

The aim of this pilot study was to investigate the effect of agglomerated glucomannan, oligofructose and chromium, as part of a calorie restricted diet plan, on weight loss, satiety, satiation, mood and gut microbiome composition in a human intervention study.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTagglomerated glucomannan, oligofructose and chromium mixtureParticipants visited the University of Roehampton on three separate occasions: visit 1 (screening), visit 2 (baseline), and visit 3 (end of the trial) in total over a period of 4-weeks. During the 4-week study period, participants were instructed to replace breakfast and lunch with a shake (206 kcal/shake) each delivering 3g of the active ingredient (Mix: agglomerated glucomannan, oligofructose and chromium picolinate), and one snack bar each delivering 1.5g of the active ingredient (112 kcal/bar) in between breakfast and lunch, and lunch and dinner following by a selection of healthy dinner according to standard nutritional guidance not exceeding 1500 kcal/day. All subjects were instructed to prepare shakes by using a shaker or blender by mixing all ingredients with 200 ml of water. Participants were also instructed to consume all shakes and bars with an extra 200 ml glass of water throughout the study period.

Timeline

Start date
2018-03-12
Primary completion
2018-08-30
Completion
2018-09-30
First posted
2020-01-31
Last updated
2020-01-31

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT04250831. Inclusion in this directory is not an endorsement.